What Is the Future of Oncology? National Cancer Institute Initiatives to Improve Research, Development, and Implementation in Cancer Prevention and Treatment

Ernest Hawk; Jaye L. Viner

doi:10.1053/j.seminoncol.2006.10.012

What Is the Future of Oncology? National Cancer Institute Initiatives to Improve Research, Development, and Implementation in Cancer Prevention and Treatment

Ernest Hawk, Jaye L. Viner

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

To improve the efficiency and effectiveness with which we bring novel cancer treatment and prevention strategies into routine clinical use, the National Cancer Institute has commissioned the Clinical Trials Working Group to restructure its activities related to clinical trials. A total of 22 initiatives have been developed and are being implemented under the rubrics of Coordination, Prioritization/Scientific Quality, Standardization, Operational Efficiency, and Integrated Management. A similar model was recently applied to the newly formed Translational Research Working Group, which will focus on more efficient translation of scientific discoveries arising from the laboratory, clinic, or population into early phase clinical testing.

Original language	English (US)
Pages (from-to)	6-9
Number of pages	4
Journal	Seminars in oncology
Volume	33
Issue number	SUPPL. 11
DOIs	https://doi.org/10.1053/j.seminoncol.2006.10.012
State	Published - Dec 2006
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1053/j.seminoncol.2006.10.012

Cite this

@article{d1a81b420b9549ae834073f4c67df872,

title = "What Is the Future of Oncology? National Cancer Institute Initiatives to Improve Research, Development, and Implementation in Cancer Prevention and Treatment",

abstract = "To improve the efficiency and effectiveness with which we bring novel cancer treatment and prevention strategies into routine clinical use, the National Cancer Institute has commissioned the Clinical Trials Working Group to restructure its activities related to clinical trials. A total of 22 initiatives have been developed and are being implemented under the rubrics of Coordination, Prioritization/Scientific Quality, Standardization, Operational Efficiency, and Integrated Management. A similar model was recently applied to the newly formed Translational Research Working Group, which will focus on more efficient translation of scientific discoveries arising from the laboratory, clinic, or population into early phase clinical testing.",

author = "Ernest Hawk and Viner, {Jaye L.}",

year = "2006",

month = dec,

doi = "10.1053/j.seminoncol.2006.10.012",

language = "English (US)",

volume = "33",

pages = "6--9",

journal = "Seminars in oncology",

issn = "0093-7754",

publisher = "W.B. Saunders Ltd",

number = "SUPPL. 11",

}

TY - JOUR

T1 - What Is the Future of Oncology? National Cancer Institute Initiatives to Improve Research, Development, and Implementation in Cancer Prevention and Treatment

AU - Hawk, Ernest

AU - Viner, Jaye L.

PY - 2006/12

Y1 - 2006/12

N2 - To improve the efficiency and effectiveness with which we bring novel cancer treatment and prevention strategies into routine clinical use, the National Cancer Institute has commissioned the Clinical Trials Working Group to restructure its activities related to clinical trials. A total of 22 initiatives have been developed and are being implemented under the rubrics of Coordination, Prioritization/Scientific Quality, Standardization, Operational Efficiency, and Integrated Management. A similar model was recently applied to the newly formed Translational Research Working Group, which will focus on more efficient translation of scientific discoveries arising from the laboratory, clinic, or population into early phase clinical testing.

AB - To improve the efficiency and effectiveness with which we bring novel cancer treatment and prevention strategies into routine clinical use, the National Cancer Institute has commissioned the Clinical Trials Working Group to restructure its activities related to clinical trials. A total of 22 initiatives have been developed and are being implemented under the rubrics of Coordination, Prioritization/Scientific Quality, Standardization, Operational Efficiency, and Integrated Management. A similar model was recently applied to the newly formed Translational Research Working Group, which will focus on more efficient translation of scientific discoveries arising from the laboratory, clinic, or population into early phase clinical testing.

UR - http://www.scopus.com/inward/record.url?scp=33845518309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845518309&partnerID=8YFLogxK

U2 - 10.1053/j.seminoncol.2006.10.012

DO - 10.1053/j.seminoncol.2006.10.012

M3 - Article

C2 - 17178278

AN - SCOPUS:33845518309

SN - 0093-7754

VL - 33

SP - 6

EP - 9

JO - Seminars in oncology

JF - Seminars in oncology

IS - SUPPL. 11

ER -

What Is the Future of Oncology? National Cancer Institute Initiatives to Improve Research, Development, and Implementation in Cancer Prevention and Treatment

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this